The DOI matches its Crossref record.
Antipyrine metabolism in man: Influence of age, alcohol, caffeine, and smoking
Abstract
Age has been shown to influence drug metabolism but effects of aging could be due to other variables that influence metabolism and differ with age. Plasma half‐life and metabolic clearance rate of antipyrine were studied in 307 healthy male subjects, aged 18 to 92. Half‐life was 16.5 % longer and metabolic clearance rate was 18.5% less in a group of the older than in the younger subjects. Alcohol consumption, caffeine consumption, and cigarette smoking all were lower in the older subjects. Both caffeine and cigarette use were positively correlated with the rate of antipyrine metabolism. Multiple regression analysis showed that the effect of smoking was partially responsible for the age differences in antipyrine metabolism. Smoking explained 12% of the variance in metabolic clearance rate and age explained 3%. Our results suggest that studies attempting to quantify the effects of aging on drug metabolism must also take into account other factors that differ with age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Patsalos, P. N., Berry, D. J., Bourgeois, B. F. D., Cloyd, J. C., Glauser, T. A., Johannessen, S. I., Leppik, I. E., Tomson, T., & Perucca, E. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01561.x · Cited by 1,156
Pharmacokinetics and drug metabolism in the elderly
Klotz, U. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902722679 · Cited by 826
“In three different studies (Vestal et al., 1975; Greenblatt et al., 1982; Sotaniemi et al., 1997), an approximately 20–25% decline in the CL of antipyrine has been observed in subjects (patients) between the age of 25 and 75 years.”
BackgroundThe effect of age upon liver volume and apparent liver blood flow in healthy man
Wynne, H. A., Cope, L. H., Mutch, E., Rawlins, M. D., Woodhouse, K. W., & James, O. F. W. (1989) · Hepatology · doi:10.1002/hep.1840090222 · Cited by 652
Street, J. S. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.968 · Cited by 590
Greenblatt (1982) · doi:10.1056/nejm198205063061804 · Cited by 584
Sotaniemi, E. A., Arranto, A. J., Pelkonen, O., & Pasanen, M. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90166-1 · Cited by 415
Management of drug therapy in the elderly
Desforges, J. F., Montamat, S. C., Cusack, B. J., & Vestal, R. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210507 · Cited by 388
Self-citationIncreased sensitivity to nitrazepam in old age
Castleden, C. M., George, C. F., Marcer, D., & Hallett, C. (1977) · BMJ · doi:10.1136/bmj.1.6052.10 · Cited by 320
The Ambiguous Relation between Aging and Adverse Drug Reactions
Gurwitz, J. H., & Avorn, J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-11-956 · Cited by 313
Drug Use in the Elderly: A Review of Problems and Special Considerations
Vestal, R. E. (1978) · Drugs · doi:10.2165/00003495-197816040-00004 · Cited by 287
Self-citationOUSLANDER, J. G. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-6-711 · Cited by 281
Use of Serum Creatinine Concentrations to Determine Renal Function1
Bjornsson, T. D. (1979) · Clinical Pharmacokinetics · doi:10.2165/00003088-197904030-00003 · Cited by 276
Age as a determinant of sensitivity to warfarin.
Shepherd, A., Hewick, D., Moreland, T., & Stevenson, I. (1977) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1977.tb00719.x · Cited by 262
Pharmacokinetics in older persons
Cusack, B. J. (2004) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2004.12.005 · Cited by 253
Pharmacokinetics of methylprednisolone in elderly and young healthy males
Tornatore, K. M., Logue, G., Venuto, R. C., & Davis, P. J. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06219.x · Cited by 38
Metadata
- Authors
- Vestal, R. E., Norris, A. H., Tobin, J. D., Cohen, B. H., Shock, N. W., & Andres, R.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1975-10
- Volume
- 18
- Issue
- 4
- Pages
- 425-432
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W114438298
- Cited by
- 318
- References
- 0
- FWCI
- 17.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.